BAMBI and non-small cell lung carcinoma: Viaanalyzing the expression profile GSE74706, Marwitzet al. (26) found that reduced bone morphogeneticprotein and activin membrane-bound inhibitor (BAMBI)contributes to the invasiveness of NSCLC and TGF-ßsignaling serves a candidate target for treating the disease.Nevertheless, the above studies have not conductedcomprehensive bioinformatics analyses to identify themolecular mechanisms of NSCLC.